Search - tctmd.com

Displaying 81 - 100 of 483

Sort: Relevancy | Date

News Conference News EuroPCR 2022

Changes in Cardiac Damage After AVR Tied to 2-Year Outcomes

Caitlin E. Cox

May 17, 2022

News Daily News

Surgical Societies Question VARC-3 Endpoints for Valve Disease Trials

Michael O'Riordan

March 23, 2022

Presentation TCT 2021

A Validation Study of the OpSens LV Pressure Guidewire

Presenter: Philippe Genereux

November 05, 2021

Presentation TCT 2021

Evaluation of the OpSens OptoWire III and its Novel TAVR Algorithm to Measure Pressure Gradient before and After TAVR Compared With Hemodynamic Value Derived by Catheterization and Echocardiogram

Presenter: Philippe Genereux

November 05, 2021

News Daily News

Good TAVI Outcomes in Young Patients, but Population Is Unique

Michael O'Riordan

October 22, 2021

News Daily News

VALVENOR Study Helps Clarify Risks in Moderate AS Patients

L.A. McKeown

October 01, 2021

Presentation TVT 2021

IVL and how it can assist your quest to stay femoral

Presenter: Philippe Genereux

July 21, 2021

News Conference News ACC 2021

ATLANTIS: Apixaban Has No Benefit Over Standard of Care Post-TAVI

Yael L. Maxwell

May 15, 2021

News Daily News

New VARC-3 Definitions Provide a Road Map for Future Aortic Valve Research

Michael O'Riordan

April 23, 2021

News Daily News

Surgery Beneficial Even in Early-Stage Aortic Stenosis, RECOVERY Hints

L.A. McKeown

January 25, 2021

News Daily News

Pandemic Prompts Closer Look at Same-Day Discharge After TAVI

Yael L. Maxwell

January 08, 2021

Presentation TCT 2020

TAVR in Low Surgical Risk Patients - Intervention (Surgery or TAVR) in Severe Asymptomatic Aortic Stenosis: Evidence Updates

Presenter: Philippe Genereux

October 16, 2020

News Daily News

‘Watchful Waiting’ Spells More Death in Asymptomatic AS, Meta-analysis Confirms

L.A. McKeown

July 17, 2020

News Conference News EuroPCR 2020

ViV TAVR: New Durability and BASILICA Data Stress Need to Plan Ahead

Yael L. Maxwell

July 03, 2020

News Daily News

Infective Endocarditis After TAVR Rare but Has Serious Consequences: SwissTAVI

L.A. McKeown

June 16, 2020

News Conference News PCR London Valves 2019

Signal of Impaired Sapien XT Durability in Midterm Follow-up

Michael O'Riordan

November 20, 2019

News Conference News PCR London Valves 2019

Real-world Data Show MitraClip Benefit in COAPT-Ineligible Patients

Michael O'Riordan

November 17, 2019

News Daily News TCT 2019

BLADE-PCI: Antirestenotic Drug Flops in Diabetics, but Inflammation Hypothesis Lives On

L.A. McKeown

October 02, 2019

News Conference News TCT 2019

TAVR Improves Health Status Over Surgery in Low-Risk Patients at 1 Year: PARTNER 3

Yael L. Maxwell

September 29, 2019

Presentation TCT 2019

BLADE-PCI: A Randomized Trial of Liposomal Alendronate in Patients With Diabetes Undergoing PCI

Presenter: Philippe Genereux

September 29, 2019

Advertisement

Changes in Cardiac Damage After AVR Tied to 2-Year Outcomes

Surgical Societies Question VARC-3 Endpoints for Valve Disease Trials

A Validation Study of the OpSens LV Pressure Guidewire

Evaluation of the OpSens OptoWire III and its Novel TAVR Algorithm to Measure Pressure Gradient before and After TAVR Compared With Hemodynamic Value Derived by Catheterization and Echocardiogram

Good TAVI Outcomes in Young Patients, but Population Is Unique

VALVENOR Study Helps Clarify Risks in Moderate AS Patients

IVL and how it can assist your quest to stay femoral

ATLANTIS: Apixaban Has No Benefit Over Standard of Care Post-TAVI

New VARC-3 Definitions Provide a Road Map for Future Aortic Valve Research

Surgery Beneficial Even in Early-Stage Aortic Stenosis, RECOVERY Hints

Pandemic Prompts Closer Look at Same-Day Discharge After TAVI

TAVR in Low Surgical Risk Patients - Intervention (Surgery or TAVR) in Severe Asymptomatic Aortic Stenosis: Evidence Updates

‘Watchful Waiting’ Spells More Death in Asymptomatic AS, Meta-analysis Confirms

ViV TAVR: New Durability and BASILICA Data Stress Need to Plan Ahead

Infective Endocarditis After TAVR Rare but Has Serious Consequences: SwissTAVI

Signal of Impaired Sapien XT Durability in Midterm Follow-up

Real-world Data Show MitraClip Benefit in COAPT-Ineligible Patients

BLADE-PCI: Antirestenotic Drug Flops in Diabetics, but Inflammation Hypothesis Lives On

TAVR Improves Health Status Over Surgery in Low-Risk Patients at 1 Year: PARTNER 3

BLADE-PCI: A Randomized Trial of Liposomal Alendronate in Patients With Diabetes Undergoing PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content